|
Oct 11
|
Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes
|
|
Oct 11
|
Update: Teva Pharmaceutical to Pay $450 Million to Settle Anti-Kickback Allegations
|
|
Oct 10
|
Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations
|
|
Oct 10
|
Teva to pay $450 million to resolve US kickback, price-fixing cases
|
|
Oct 9
|
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ...
|
|
Oct 8
|
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
|
|
Oct 7
|
Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now?
|
|
Oct 7
|
Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?
|
|
Jul 29
|
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
|
|
Jul 29
|
Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
|
|
Jul 25
|
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
|
|
Jun 13
|
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
|
|
Feb 16
|
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript
|
|
Feb 16
|
Q4 2023 Corcept Therapeutics Inc Earnings Call
|
|
Feb 13
|
Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight
|
|
Feb 12
|
Teva Pharmaceutical upgraded at Piper Sandler
|
|
Jan 12
|
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
|
|
Jan 10
|
3 No-Brainer Stocks to Buy With $20 Right Now
|
|
Jan 2
|
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
|
|
Jan 2
|
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
|